Galleri®

Multi-Cancer Early Detection Test
A Proactive Tool To Screen For Cancer

Galleri is a multi-cancer early detection test, a blood test that screens for many of the deadliest cancers before they become symptomatic, including those with no recommended screening tests today.

Have Confidence in Knowing You've Done More to Screen for Cancer

Cancer often hides, with symptoms not appearing until later stages. The earlier that cancer is diagnosed, the greater the chance of successful treatment and survival.

Backed by rigorous clinical evidence, the Galleri test gives you more control when it comes to cancer screenings.

The Galleri test can be taken annually as a simple blood test and screens for a “fingerprint” of many of the deadliest cancers before they become symptomatic, including those with no recommended screening tests today.

Aggressive cancers can develop quickly and without symptoms. Cancers growing in the body shed DNA into the bloodstream, the DNA fragments can act like a unique "fingerprint" of cancer. The Galleri test may be able to detect such a “fingerprint” before a clinical diagnosis through conventional means.

How Does the Galleri Test Work?

Cancers growing in the body shed DNA into the bloodstream. Although there are many types of cancer, the DNA fragments can act like a unique “fingerprint” of cancer.

The Galleri test screens for many of the deadliest cancers before they become symptomatic, including those without recommended screening tests. The test results provide a predicted Cancer Signal Origin to help us determine the next steps for diagnosis.

What The Galleri Test Detects

  • Adrenal Cortical Carcinoma

    Ampulla of Vater

    Anus

    Appendix, Carcinoma

    Bile Ducts, Distal

    Bile Ducts, Intrahepatic

    Bile Ducts, Perihilar

    Bladder, Urinary

    Bone

    Breast

    Cervix

    Colon and Rectum

    Esophagus and Esophagogastric Junction

    Gallbladder

    Gastrointestinal Stromal Tumor

    Gestational Trophoblastic Neoplasms

    Kidney

    Larynx

    Leukemia

    Liver

    Lung

    Lymphoma (Hodgkin and Non-Hodgkin)

    Melanoma of the Skin

    Merkel Cell Carcinoma

    Mesothelioma, Malignant Pleural

    Nasal Cavity and Paranasal Sinuses Nasopharynx

    Neuroendocrine Tumors of the Appendix

    Neuroendocrine Tumors of the Colon and Rectum

    Neuroendocrine Tumors of the Pancreas

    Oral Cavity

    Oropharynx (HPV-Mediated, p16+)

    Oropharynx (p16-) and Hypopharynx

    Ovary, Fallopian Tube and Primary Peritoneum

    Pancreas, exocrine

    Penis

    Plasma Cell Myeloma and Plasma Cell Disorders

    Prostate

    Small Intestine

    Soft Tissue Sarcoma of the Abdomen and Thoracic Visceral Organs

    Soft Tissue Sarcoma of the Head and Neck

    Soft Tissue Sarcoma of the Retroperitoneum

    Soft Tissue Sarcoma of the Trunk and Extremities

    Soft Tissue Sarcoma Unusual Histologies and Sites

    Stomach

    Testis

    Ureter, Renal Pelvis

    Uterus, Carcinoma and Carcinosarcoma

    Uterus, Sarcoma

    Vagina

    Vulva

Looking for peace of mind?
Screen for over 50 cancers with just one simple test.

Understanding Your Results

You will receive your test result about two weeks after your blood sample is received at the GRAIL lab.

There are two possible results:

- No Cancer Signal Detected 
- Cancer Signal Detected

Nearly 99% of people who use the Galleri test will screen negative — which is exactly what you want to hear. Continue with routine cancer screening tests your healthcare provider recommends.

If a cancer signal is found, results also can predict the tissue type or organ associated with the cancer signal. This vital information will then help guide us with the next steps.